Trial Profile
A Pilot Study Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole 60 mg and Esomeprazole 40 mg for Gastroesophageal Reflux Disease Grade A and B
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Apr 2017
Price :
$35
*
At a glance
- Drugs Dexlansoprazole (Primary) ; Esomeprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 27 Apr 2017 New trial record